FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3017360478> ?p ?o ?g. }

• W3017360478 abstract "Molecular targeted drugs are the first line of treatment of advanced hepatocellular carcinoma (HCC) due to its chemo- and radioresistant nature. HCC has several well-documented etiologic factors that drive hepatocarcinogenesis through different molecular pathways. Currently, hepatitis C virus (HCV) is a leading cause of HCC. Therefore, we included a unified cohort of HCV genotype 4-related HCCs to study the expression levels of genes involved in the insulin-like growth factor 1 receptor (IGF1R) pathway, which is known to be involved in all aspects of cancer growth and progression.Determine the gene expression patterns of IGF1R pathway genes in a cohort of Egyptian HCV-related HCCs. Correlate them with different patient/tumor characteristics. Determine the activity status of involved pathways.Total ribonucleic acid (RNA) was extracted from 32 formalin-fixed paraffin-embedded tissues of human HCV-related HCCs and 6 healthy liver donors as controls. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) using RT2 Profiler PCR Array for Human Insulin Signaling Pathway was done to determine significantly up- and downregulated genes with identification of most frequently coregulated genes, followed by correlation of gene expression with different patient/tumor characteristics. Finally, canonical pathway analysis was performed using the Ingenuity Pathway Analysis software.Six genes - AEBP1, AKT2, C-FOS, PIK3R1, PRKCI, SHC1 - were significantly overexpressed. Thirteen genes - ADRB3, CEBPA, DUSP14, ERCC1, FRS3, IGF2, INS, IRS1, JUN, MTOR, PIK3R2, PPP1CA, RPS6KA1 - were significantly underexpressed. Several differentially expressed genes were related to different tumor/patient characteristics. Nitric oxide and reactive oxygen species production pathway was significantly activated in the present cohort, while the growth hormone signaling pathway was inactive.The gene expression patterns identified in this study may serve as possible therapeutic targets in HCV-related HCCs. The most frequently coregulated genes may serve to guide combined molecular targeted therapies. The IGF1R pathway showed evidence of inactivity in the present cohort of HCV-related HCCs, so targeting this pathway in therapy may not be effective." @default.
• W3017360478 created "2020-04-24" @default.
• W3017360478 creator A5001190032 @default.
• W3017360478 creator A5018586862 @default.
• W3017360478 creator A5022031981 @default.
• W3017360478 creator A5022329038 @default.
• W3017360478 creator A5034881080 @default.
• W3017360478 creator A5035582765 @default.
• W3017360478 creator A5041934163 @default.
• W3017360478 creator A5054372598 @default.
• W3017360478 creator A5083491617 @default.
• W3017360478 date "2020-04-08" @default.
• W3017360478 modified "2023-09-27" @default.
• W3017360478 title "Identification of the possible therapeutic targets in the insulin-like growth factor 1 receptor pathway in a cohort of Egyptian hepatocellular carcinoma complicating chronic hepatitis C type 4" @default.
• W3017360478 cites W1541275300 @default.
• W3017360478 cites W1853387493 @default.
• W3017360478 cites W1863396492 @default.
• W3017360478 cites W1910462481 @default.
• W3017360478 cites W1935714551 @default.
• W3017360478 cites W1964301645 @default.
• W3017360478 cites W1966137062 @default.
• W3017360478 cites W1969988478 @default.
• W3017360478 cites W1971113363 @default.
• W3017360478 cites W1975088494 @default.
• W3017360478 cites W1980739790 @default.
• W3017360478 cites W2000074317 @default.
• W3017360478 cites W2001219721 @default.
• W3017360478 cites W2003735188 @default.
• W3017360478 cites W2011429571 @default.
• W3017360478 cites W2018808567 @default.
• W3017360478 cites W2019574453 @default.
• W3017360478 cites W2020002352 @default.
• W3017360478 cites W2022531340 @default.
• W3017360478 cites W2023815439 @default.
• W3017360478 cites W2026157651 @default.
• W3017360478 cites W2032352097 @default.
• W3017360478 cites W2036922484 @default.
• W3017360478 cites W2047770640 @default.
• W3017360478 cites W2051839343 @default.
• W3017360478 cites W2051984702 @default.
• W3017360478 cites W2059549015 @default.
• W3017360478 cites W2067232729 @default.
• W3017360478 cites W2068145282 @default.
• W3017360478 cites W2086307737 @default.
• W3017360478 cites W2086880360 @default.
• W3017360478 cites W2091634364 @default.
• W3017360478 cites W2094425604 @default.
• W3017360478 cites W2095731186 @default.
• W3017360478 cites W2099789788 @default.
• W3017360478 cites W2101791772 @default.
• W3017360478 cites W2105912300 @default.
• W3017360478 cites W2117030318 @default.
• W3017360478 cites W2117184493 @default.
• W3017360478 cites W2119389886 @default.
• W3017360478 cites W2121436678 @default.
• W3017360478 cites W2123431135 @default.
• W3017360478 cites W2130701570 @default.
• W3017360478 cites W2131411117 @default.
• W3017360478 cites W2137044945 @default.
• W3017360478 cites W2137988967 @default.
• W3017360478 cites W2138845988 @default.
• W3017360478 cites W2144838596 @default.
• W3017360478 cites W2148233444 @default.
• W3017360478 cites W2149193758 @default.
• W3017360478 cites W2158378236 @default.
• W3017360478 cites W2161587712 @default.
• W3017360478 cites W2172216599 @default.
• W3017360478 cites W2203276755 @default.
• W3017360478 cites W2229731086 @default.
• W3017360478 cites W2287212130 @default.
• W3017360478 cites W2297822018 @default.
• W3017360478 cites W2464937318 @default.
• W3017360478 cites W248861484 @default.
• W3017360478 cites W2496029366 @default.
• W3017360478 cites W2732104112 @default.
• W3017360478 cites W2743924351 @default.
• W3017360478 cites W2775414517 @default.
• W3017360478 cites W2792615707 @default.
• W3017360478 cites W2793761009 @default.
• W3017360478 cites W2793961245 @default.
• W3017360478 cites W4232614050 @default.
• W3017360478 cites W82787745 @default.
• W3017360478 doi "https://doi.org/10.33393/dti.2020.1548" @default.
• W3017360478 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7597224" @default.
• W3017360478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33132693" @default.
• W3017360478 hasPublicationYear "2020" @default.
• W3017360478 type Work @default.
• W3017360478 sameAs 3017360478 @default.
• W3017360478 citedByCount "1" @default.
• W3017360478 countsByYear W30173604782021 @default.
• W3017360478 crossrefType "journal-article" @default.
• W3017360478 hasAuthorship W3017360478A5001190032 @default.
• W3017360478 hasAuthorship W3017360478A5018586862 @default.
• W3017360478 hasAuthorship W3017360478A5022031981 @default.
• W3017360478 hasAuthorship W3017360478A5022329038 @default.
• W3017360478 hasAuthorship W3017360478A5034881080 @default.
• W3017360478 hasAuthorship W3017360478A5035582765 @default.
• W3017360478 hasAuthorship W3017360478A5041934163 @default.
• W3017360478 hasAuthorship W3017360478A5054372598 @default.
• W3017360478 hasAuthorship W3017360478A5083491617 @default.

• next